Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
44.29
+0.81 (1.86%)
At close: Mar 9, 2026
SHA:688273 Revenue
In the year 2025, Nanjing Medlander Medical Technology had annual revenue of 431.59M CNY with 1.66% growth. Nanjing Medlander Medical Technology had revenue of 87.75M in the quarter ending December 31, 2025, a decrease of -6.62%.
Revenue
431.59M
Revenue Growth
+1.66%
P/S Ratio
10.04
Revenue / Employee
741.57K
Employees
566
Market Cap
4.33B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getein Biotech | 1.04B |
| Ningbo David Medical Device | 516.76M |
| Shanghai Kinetic Medical | 1.02B |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |
| Zhejiang Orient Gene Biotech | 958.99M |
| Medprin Regenerative Medical Technologies | 336.73M |
| Hangzhou AGS MedTech | 597.21M |
| Beijing Leadman Biochemistry | 340.65M |